Novel DBS Stimulation Patterns for Treatment of Parkinson's Disease Trial N/A Recruiting July 21, 2026
Behavioral and/or Mirabegron to Treat Urinary Symptoms in Parkinson Disease Trial Phase 4 Not yet recruiting July 21, 2026
Intranasal Insulin and Glutathione as an Add-On Therapy in Parkinson's Disease Trial Phase 2 Recruiting July 21, 2026
ZR001 Chemogenetics Gene Therapy Study in Patients With Parkinson's Disease Trial Phase 1 Not yet recruiting July 21, 2026
Parkinson’s Research at Emory University’s APDA Center for Advanced Research News A Closer Look Archives | American Parkinson Disease Association July 21, 2026
Doctors look beyond test scores to spot cognitive changes in Parkinson’s News Parkinson's News Today – The Web's Daily Resource for Parkinson's News July 21, 2026
Parkinson’s symptoms can make daily mouth care harder to maintain News Parkinson's News Today – The Web's Daily Resource for Parkinson's News July 21, 2026
Subthalamic Nucleus (STN)-Targeted Transcranial Temporal Interference Stimulation (TIS) for Parkinson's Disease: Efficacy and Safety From a Single-Center, Prospective, Double-Blind Randomized Controlled Trial Trial N/A Completed July 20, 2026
Accelerated Temporal Interference Stimulation on Bilateral Subthalamic Nucleus for Parkinson's Disease and Secondary Parkinson's Syndrome Trial N/A Recruiting July 20, 2026
The Impact of Deep Brain Stimulation on Speech and Swallow Function in Parkinson Disease Trial N/A Recruiting July 20, 2026
Muscle mass alone does not explain fitness drops in Parkinson’s News Parkinson's News Today – The Web's Daily Resource for Parkinson's News July 20, 2026
Return of genetic results to persons with Parkinson's disease: Blessing or foe? News SAGE Publications: Journal of Parkinson’s Disease: Table of Contents July 19, 2026
A Multifactorial Exercise Program to Reduce Falls in People With Parkinson Disease Trial N/A Completed July 19, 2026
The Efficacy and Safety of Temporal Interference Stimulation on Motor Symptoms of Parkinson's Disease Trial N/A Recruiting July 19, 2026
A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor Fluctuations Trial Phase 2 Recruiting July 19, 2026
Artificial Intelligence-based Parkinson's Disease Risk Assessment (AI-PRA) Study Trial N/A Not yet recruiting July 19, 2026